Search

- Jun 4
Antibody-drug conjugates at #ASCO23 with Seagen’s David Epstein
Seagen CEO David Epstein talks about moving antibody-drug conjugates into broader indications at #ASCO23.

- Jan 11
Antibody-drug conjugates with David Epstein
Seagen's David Epstein talks about antibody-drug conjugates at #JPM23.